A Detailed Look at Cannabis Sales in California, Oregon, Arizona, Colorado and Nevada
Data provided by BDSA indicates that cannabis sales continued their robust expansion in 5 Western states, though seasonal trends resulted in declines from the prior month. During September, the first anniversary of the vaping crisis and the seventh month of the pandemic impacting the market, sales across the five markets totaled $805.9 million, down 4% from August, which followed a 1% sequential decline in July, and sequential increases of 12% in June, 2% in May and 14% in April. March had spiked dramatically to $666.0 million from $579.9 million in February as customers purchased cannabis ahead of store closures and concerns about limitations on access. With the near-term effects of the pandemic now behind us, it’s clear that cannabis demand is surging, even in relatively mature markets, like Oregon and Colorado.
Overall sales growth from a year ago among the five Western markets ranged from 32% in Colorado to as high as 43% in Nevada. Arizona grew 39%, while Oregon continued its strong growth, rising 38%. The largest market, California, grew 33%, its third consecutive month of strong gains after a long period of being relatively flat growth. Note that the comparisons to a year ago were easier given that the sales began to be impacted negatively by the vaping crisis a year ago, but, with the exception of Arizona, growth in flower exceeded growth in concentrates in all markets.
Here is a closer look at each market, as detailed by BDSA:
In September 2020, cannabis sales in Arizona’s medical dispensaries reached $85.4 million, declining seven percent from August. Compared to the previous September, sales in Arizona grew over 39 percent. Year-to-date through September, sales have reached $766.8 million, increasing by $247.6 million and 48